1. Home
  2. TASK vs ARVN Comparison

TASK vs ARVN Comparison

Compare TASK & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TaskUs Inc.

TASK

TaskUs Inc.

HOLD

Current Price

$5.08

Market Cap

544.9M

Sector

Technology

ML Signal

HOLD

Logo Arvinas Inc.

ARVN

Arvinas Inc.

HOLD

Current Price

$8.39

Market Cap

516.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TASK
ARVN
Founded
2008
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
544.9M
516.2M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
TASK
ARVN
Price
$5.08
$8.39
Analyst Decision
Hold
Buy
Analyst Count
5
19
Target Price
$14.70
$15.05
AVG Volume (30 Days)
617.9K
741.1K
Earning Date
05-06-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
120.00
58.84
EPS
0.26
N/A
Revenue
N/A
$262,600,000.00
Revenue This Year
$5.95
N/A
Revenue Next Year
$6.46
N/A
P/E Ratio
$19.35
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.47
$6.06
52 Week High
$18.39
$14.22

Technical Indicators

Market Signals
Indicator
TASK
ARVN
Relative Strength Index (RSI) 42.57 54.11
Support Level $4.47 N/A
Resistance Level $6.62 $10.18
Average True Range (ATR) 0.30 0.44
MACD 0.03 0.17
Stochastic Oscillator 46.32 82.39

Price Performance

Historical Comparison
TASK
ARVN

About TASK TaskUs Inc.

TaskUs Inc provides outsourced digital services. Its service offerings include Digital Customer Experience consists of omnichannel customer care services, delivered through digital (non-voice) channels, also including learning experience and sales and customer acquisition services; Trust & Safety consists of monitoring, reviewing and managing user and advertiser-generated content on online platforms to ensure it complies with community guidelines, legal regulations and platform specific policies; and AI Services consists of large language model support and high-quality data labeling services, annotation, context relevance and transcription services performed for the purpose of training and tuning machine learning algorithms, enabling them to develop cutting-edge AI systems.

About ARVN Arvinas Inc.

Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.

Share on Social Networks: